Gilead Sciences, Inc.
ANTIBODIES THAT TARGET HIV GP120 AND METHODS OF USE
Last updated:
Abstract:
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Status:
Application
Type:
Utility
Filling date:
7 Oct 2021
Issue date:
24 Mar 2022